Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

A new scientific statement highlights new clinical data related to diagnosis, risk classification and treatment, emphasizing the need for tailored management strategies. Advances in cardiac imaging ...